Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRA

Minoru Kuroiwa, Mitsuteru Hiwatari, Junko Hirato, Norio Suzuki, Yoshiaki Tsuchida, Akira Shimada, Toshiji Shitara, Tomohiko Taki, Yasuhide Hayashi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A 12-year-old girl presented with a large abdominal tumor. At surgery, a huge pedunculated extraluminal tumor was found arising from the greater curvature of the stomach and invading the surrounding structures, and there were also a submucosal tumor measuring 5 × 4 × 4 cm and multiple intramural nodules beside the main tumor. These lesions, which were removed with 1.0-cm surgical margins, were immunohistochemically positive for c-kit (CD117) and CD34. A diagnosis of gastrointestinal stromal tumor (GIST) was made. The huge size of the tumor (3.6 kg in weight and 36 × 25 × 25 cm in diameter), the invasion of the surrounding structures, and the increased mitotic figures indicated the GIST had malignant potential. Sequence analysis of the polymerase chain reaction product of RNAs from the tumor cells revealed a novel platelet-derived growth factor receptor α (PDGFRA) mutation, which would exhibit biologic consequences similar to those of the c-kit mutation. The patient underwent a 3-month course of imatinib mesylate as adjuvant chemotherapy because of the possible risk for tumor recurrence. She is now doing well without any evidence of recurrence or metastasis 25 months after the surgery. Only 9 cases of GIST have been reported in children, and a review of those cases revealed GISTs in children would be associated with a better prognosis than in adults and that one third of pediatric GISTs presented with intestinal obstruction in the newborn period.

Original languageEnglish
Pages (from-to)1798-1801
Number of pages4
JournalJournal of Pediatric Surgery
Volume40
Issue number11
DOIs
Publication statusPublished - Nov 2005
Externally publishedYes

Fingerprint

Gastrointestinal Stromal Tumors
Mutation
Neoplasms
Platelet-Derived Growth Factor Receptors
Recurrence
Intestinal Obstruction
Adjuvant Chemotherapy
Imatinib Mesylate
Sequence Analysis
Stomach
Newborn Infant
RNA
Pediatrics
Neoplasm Metastasis
Weights and Measures
Polymerase Chain Reaction

Keywords

  • c-kit
  • Gastrointestinal stromal tumor
  • Gleevec
  • Imatinib
  • PDGFRA
  • STI571

ASJC Scopus subject areas

  • Surgery

Cite this

Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRA. / Kuroiwa, Minoru; Hiwatari, Mitsuteru; Hirato, Junko; Suzuki, Norio; Tsuchida, Yoshiaki; Shimada, Akira; Shitara, Toshiji; Taki, Tomohiko; Hayashi, Yasuhide.

In: Journal of Pediatric Surgery, Vol. 40, No. 11, 11.2005, p. 1798-1801.

Research output: Contribution to journalArticle

Kuroiwa, Minoru ; Hiwatari, Mitsuteru ; Hirato, Junko ; Suzuki, Norio ; Tsuchida, Yoshiaki ; Shimada, Akira ; Shitara, Toshiji ; Taki, Tomohiko ; Hayashi, Yasuhide. / Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRA. In: Journal of Pediatric Surgery. 2005 ; Vol. 40, No. 11. pp. 1798-1801.
@article{7944bd227f8c4004ad73e7be822b28ba,
title = "Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRA",
abstract = "A 12-year-old girl presented with a large abdominal tumor. At surgery, a huge pedunculated extraluminal tumor was found arising from the greater curvature of the stomach and invading the surrounding structures, and there were also a submucosal tumor measuring 5 × 4 × 4 cm and multiple intramural nodules beside the main tumor. These lesions, which were removed with 1.0-cm surgical margins, were immunohistochemically positive for c-kit (CD117) and CD34. A diagnosis of gastrointestinal stromal tumor (GIST) was made. The huge size of the tumor (3.6 kg in weight and 36 × 25 × 25 cm in diameter), the invasion of the surrounding structures, and the increased mitotic figures indicated the GIST had malignant potential. Sequence analysis of the polymerase chain reaction product of RNAs from the tumor cells revealed a novel platelet-derived growth factor receptor α (PDGFRA) mutation, which would exhibit biologic consequences similar to those of the c-kit mutation. The patient underwent a 3-month course of imatinib mesylate as adjuvant chemotherapy because of the possible risk for tumor recurrence. She is now doing well without any evidence of recurrence or metastasis 25 months after the surgery. Only 9 cases of GIST have been reported in children, and a review of those cases revealed GISTs in children would be associated with a better prognosis than in adults and that one third of pediatric GISTs presented with intestinal obstruction in the newborn period.",
keywords = "c-kit, Gastrointestinal stromal tumor, Gleevec, Imatinib, PDGFRA, STI571",
author = "Minoru Kuroiwa and Mitsuteru Hiwatari and Junko Hirato and Norio Suzuki and Yoshiaki Tsuchida and Akira Shimada and Toshiji Shitara and Tomohiko Taki and Yasuhide Hayashi",
year = "2005",
month = "11",
doi = "10.1016/j.jpedsurg.2005.07.066",
language = "English",
volume = "40",
pages = "1798--1801",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRA

AU - Kuroiwa, Minoru

AU - Hiwatari, Mitsuteru

AU - Hirato, Junko

AU - Suzuki, Norio

AU - Tsuchida, Yoshiaki

AU - Shimada, Akira

AU - Shitara, Toshiji

AU - Taki, Tomohiko

AU - Hayashi, Yasuhide

PY - 2005/11

Y1 - 2005/11

N2 - A 12-year-old girl presented with a large abdominal tumor. At surgery, a huge pedunculated extraluminal tumor was found arising from the greater curvature of the stomach and invading the surrounding structures, and there were also a submucosal tumor measuring 5 × 4 × 4 cm and multiple intramural nodules beside the main tumor. These lesions, which were removed with 1.0-cm surgical margins, were immunohistochemically positive for c-kit (CD117) and CD34. A diagnosis of gastrointestinal stromal tumor (GIST) was made. The huge size of the tumor (3.6 kg in weight and 36 × 25 × 25 cm in diameter), the invasion of the surrounding structures, and the increased mitotic figures indicated the GIST had malignant potential. Sequence analysis of the polymerase chain reaction product of RNAs from the tumor cells revealed a novel platelet-derived growth factor receptor α (PDGFRA) mutation, which would exhibit biologic consequences similar to those of the c-kit mutation. The patient underwent a 3-month course of imatinib mesylate as adjuvant chemotherapy because of the possible risk for tumor recurrence. She is now doing well without any evidence of recurrence or metastasis 25 months after the surgery. Only 9 cases of GIST have been reported in children, and a review of those cases revealed GISTs in children would be associated with a better prognosis than in adults and that one third of pediatric GISTs presented with intestinal obstruction in the newborn period.

AB - A 12-year-old girl presented with a large abdominal tumor. At surgery, a huge pedunculated extraluminal tumor was found arising from the greater curvature of the stomach and invading the surrounding structures, and there were also a submucosal tumor measuring 5 × 4 × 4 cm and multiple intramural nodules beside the main tumor. These lesions, which were removed with 1.0-cm surgical margins, were immunohistochemically positive for c-kit (CD117) and CD34. A diagnosis of gastrointestinal stromal tumor (GIST) was made. The huge size of the tumor (3.6 kg in weight and 36 × 25 × 25 cm in diameter), the invasion of the surrounding structures, and the increased mitotic figures indicated the GIST had malignant potential. Sequence analysis of the polymerase chain reaction product of RNAs from the tumor cells revealed a novel platelet-derived growth factor receptor α (PDGFRA) mutation, which would exhibit biologic consequences similar to those of the c-kit mutation. The patient underwent a 3-month course of imatinib mesylate as adjuvant chemotherapy because of the possible risk for tumor recurrence. She is now doing well without any evidence of recurrence or metastasis 25 months after the surgery. Only 9 cases of GIST have been reported in children, and a review of those cases revealed GISTs in children would be associated with a better prognosis than in adults and that one third of pediatric GISTs presented with intestinal obstruction in the newborn period.

KW - c-kit

KW - Gastrointestinal stromal tumor

KW - Gleevec

KW - Imatinib

KW - PDGFRA

KW - STI571

UR - http://www.scopus.com/inward/record.url?scp=27744565616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744565616&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2005.07.066

DO - 10.1016/j.jpedsurg.2005.07.066

M3 - Article

VL - 40

SP - 1798

EP - 1801

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 11

ER -